Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Journal of Endocrinological Investigation|November 30, 2014
Cardiovascular risk factors and events in women with androgen excessD Macut, I B Antić, J Bjekić-MacutStudies in Health Technology and Informatics|February 24, 2001
Web-based multimedia courseware for emergency cardiac patient management simulationsV Ambrosiadou, T Compton, T Panchal, et al.Acta Endocrinologica (Bucharest, Romania : 2005)|January 23, 2025
SHORT HISTORY OF OBESITYD Micic, S Polovina, D Micic, et al.Clinical and Experimental Obstetrics & Gynecology|May 3, 2016
Peripartum cardiomyopathy: a case of patient with triplet pregnancyB Kastratović Kotlica, A Cetković, S Plesinac, et al.Human & Experimental Toxicology|June 14, 2013
Homocysteine thiolactone-induced seizures in adult rats are aggravated by inhibition of inducible nitric oxide synthaseD Hrnčić, A Rašić-Marković, D Macut, et al.The Journal of Clinical Endocrinology and Metabolism|July 14, 1998
Preserved growth hormone (GH) secretion in aged and very old subjects after testing with the combined stimulus GH-releasing hormone plus GH-releasing hexapeptide-6D Micic, V Popovic, M Doknic, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 10, 2011
Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndromeD Vojnović Milutinović, D Macut, I Božić, et al.Acta Physiologica Hungarica|March 11, 2011
The effect of N-methyl-D-aspartate receptor antagonists on D,L-homocysteine thiolactone induced seizures in adult ratsA Rašić-Marković, D Hrnčić, D Djurić, et al.Clinical Endocrinology|February 1, 1995
Growth hormone secretion after the administration of GHRP-6 or GHRH combined with GHRP-6 does not decline in late adulthoodD Micic, V Popovic, A Kendereski, et al.Acta Endocrinologica (Bucharest, Romania : 2005)|May 8, 2023
A non-invasive method for estimating the severity of liver steatosis and the risk of fibrosis in non-obese type 2 diabetes patients with NAFLDB Mitrovic, Z Gluvic, A Klisic, et al.Pageof 7